A Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer
Clinical trial NCT06939595 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06939595
- Sponsor
- Celltrion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-30
- Primary completion
- 2027-02-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.